MedPath

RELAX: Effect of EMDR for reduction of pain interference in children with sickle cell disease

Conditions
Sickle cell disease
Sickle cell anemia
10018902
Registration Number
NL-OMON56978
Lead Sponsor
Amsterdam UMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

• Medical diagnosis of SCD;
• Age between 6 and 18 years old;
• Elevated pain interference scores:
Reporting above the clinical cut-off t-score of 49 on PROMIS Pain
Interference (parent-proxy version for children from 6-7 years and self-report
version for children from 8 years).
• Having sufficient knowledge of the Dutch or English languages to complete the
assessments;

Exclusion Criteria

• Undergone succesful stem cell transplantation;
• Pregnant adolescents;
• Current unsafety that is likely to interfere with psychological therapy for
example ongoing domestic violence;
• Major interfering acute medical or psychiatric condition, such as psychosis,
substance dependence, current severe self-harm or high risk for suicide
requiring immediate treatment;
• Receiving psychological (trauma) treatment by another therapist at the same
time;
• IQ estimated to be < 80 based on information contained in the medical history
or information from educational services/school.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath